Kiuchi Yoshiaki, Nakae Kazuto, Saito Yoshihiro, Ito Shigeo, Ito Nami
Department of Ophthalmology, Otemae Hospital, 1-5-34 Otemae, Chuo-ku, Osaka, 540-0008, Japan.
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1627-32. doi: 10.1007/s00417-006-0321-7.
Treatment of neovascular glaucoma (NVG) must be focused on the reduction of intraocular pressure (IOP) and prompt application of pan retinal photocoagulation (PRP). A combination of complete PRP during vitrectomy with trabeculectomy should theoretically be a better method to lower the IOP rapidly in eyes with NVG. The purpose of our study is to assess the efficacy of combining pars plana vitrectomy and PRP with trabeculectomy assisted by mitomycin C (MMC) on NVG eyes secondary to diabetic retinopathy.
Twenty-five eyes with NVG associated with diabetic retinopathy had pars plana vitrectomy, followed by PRP and trabeculectomy with MMC. The eyes were divided into two groups: nine eyes with vitreous hemorrhage, fibrovascular membrane and/ or retinal detachment were placed in the Proliferation group; and 16 eyes without vitreous hemorrhage, fibrovascular membrane, or retinal detachment were placed in the PC (photocoagulation) group. These eyes had vitrectomy performed so that PRP could be safely performed from ora to ora. The surgical outcome in the two groups was assessed by Kaplan-Meier survival analysis. The criteria for success were a postoperative intraocular pressure (IOP) < or =21 mmHg and a preservation of light perception.
In the Proliferation group, Kaplan-Meier life-table analysis showed that the success rate was 55.6% after 1 year and 18.5% after 2 years. The success rate in the PC group was 81.2% from 1 to 3 years after surgery. The surgical outcome was significantly better in the PC group than in the Proliferation group (P=0.009). In the Proliferation group, four eyes had preoperative vitreous hemorrhage, three eyes had a fibrovascular membrane, and two eyes had a retinal detachment. Three of four eyes with vitreous hemorrhage achieved good IOP control. On the other hand, the IOP of all eyes with retinal detachment and fibrovascular membrane were not lowered significantly.
Complete PRP combined with trabeculectomy with MMC can effectively reduce the elevated IOP in eyes with NVG. However, this combined treatment is not effective in eyes with proliferative membranes and retinal detachments.
新生血管性青光眼(NVG)的治疗必须聚焦于降低眼压(IOP)以及及时进行全视网膜光凝(PRP)。在玻璃体切除术中完成PRP并联合小梁切除术,理论上应是能使NVG患者眼压迅速降低的更好方法。我们研究的目的是评估在丝裂霉素C(MMC)辅助下,玻璃体切除术联合PRP与小梁切除术治疗糖尿病视网膜病变继发NVG眼的疗效。
25例糖尿病视网膜病变相关的NVG患者接受了玻璃体切除术,随后进行PRP以及MMC辅助的小梁切除术。这些眼睛被分为两组:9例有玻璃体出血、纤维血管膜和/或视网膜脱离的患者被归入增殖组;16例无玻璃体出血、纤维血管膜或视网膜脱离的患者被归入PC(光凝)组。对这些眼睛进行玻璃体切除术,以便能从锯齿缘到锯齿缘安全地进行PRP。通过Kaplan-Meier生存分析评估两组的手术结果。成功标准为术后眼压(IOP)≤21 mmHg且保留光感。
在增殖组,Kaplan-Meier生存表分析显示,1年后成功率为55.6%,2年后为18.5%。PC组术后1至3年的成功率为81.2%。PC组的手术结果明显优于增殖组(P = 0.009)。在增殖组,4例术前有玻璃体出血,3例有纤维血管膜,2例有视网膜脱离。4例玻璃体出血患者中有3例眼压控制良好。另一方面,所有视网膜脱离和纤维血管膜患者的眼压均未显著降低。
全视网膜光凝联合MMC小梁切除术可有效降低NVG患者升高的眼压。然而,这种联合治疗对伴有增殖性膜和视网膜脱离的眼睛无效。